Pancreatic Cancer

We've got a sneak peek at what’s inside our Winter 2019 issue.

Alex Trebek, the long-time host of the popular game show "Jeopardy!", announced that he received a diagnosis of stage 4 pancreatic cancer.

Patients with pancreatic cancer face barriers to clinical trials as a standard of care.

A number of approved therapies can be used to treat pancreatic cancer, but many experts say that clinical trials offer patients greater hope.

Pancreatic cancer is one that strikes fear in the most stoic among us. Cancer.net tells us that although pancreatic cancer accounts for only 3% of cancer diagnoses in a given year, it is responsible for 7% of cancer deaths annually.

Adaptive clinical trials are poised to deliver hope to patients with pancreatic cancer.

SINGER ARETHA FRANKLIN, 76, died of advanced pancreatic cancer on Aug. 16 at her home in Detroit, with her family and friends at her bedside.

A genetic counselor discussed the various hereditary breast and ovarian cancer syndrome-associated cancers among men and how to manage them at the FORCE Annual Meeting.

Pancreatic cancer is a silent killer in that symptoms usually start appearing after the cancer has advanced to a stage 3 or stage 2 level.

“Sometimes ‘a new normal’ seems to have a bad connotation,” said Nicole Lise Feingold, director of Patient Services at the Pancreatic Cancer Action Network (PanCAN).

After losing her husband and sister to cancer, journalist Katie Couric became an advocate for collaborative efforts to improve prevention and treatment.

Genetic testing is becoming more important in pancreatic cancer, especially since it can point toward more efficacious treatment regimens for some patients.

Tests like these are growing increasingly important, as TOO results lead to treatment changes about 65 percent of the time and a site treatment change about 35 percent of the time, according to Cancer Genetics.

A leader of the Pancreatic Cancer Action Network, which aims to double survival rates by 2020, outlines treatment strategies that could lead to success.

“Disease control is key in our patients with locally advanced disease, as it may lead to opportunities for additional treatment interventions, including radiotherapy, or even, in some favorable cases, surgical resection,” said lead study author Pascal Hammel, M.D., Ph.D.

“There have been significant developments in our underpinnings for the development of pancreas cancer on both a molecular and genetic basis," said Eileen M. O'Reilly, M.D.

Nutrition plays a crucial role in the lives of people with cancer. But more than a million people suffering from the disease in the United States also endure a wasting syndrome called cachexia.

What role will immunotherapy play in the future treatment of GI cancers? CURE spoke to Brian Hemphill, M.D., to find out.

Experimental treatment uses engineered T cells to target prostate stem cell antigen.

A regimen without gemcitabine had promising survival rates for patients with metastatic pancreatic cancer, according to a recent study.